Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells

Journal Pharmacological Sciences

Volumn 91, Issue 3, 2003, Pages 211-218

  Kuwashima, Haruhiro ^a   Matsumura, Chiaki ^a   Kimura, Tomohiko ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

Bovine adrenal chromaffin cell; Ca2+ dependent exocytosis; Catecholamine; Pimobendan

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATE MAGNESIUM; AMRINONE; ANGIOTENSIN; BETA ESCIN; CALCIUM ION; CALCIUM SENSITIZER; CATECHOLAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; HISTAMINE; MILRINONE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NICOTINIC RECEPTOR; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PIMOBENDAN; POTASSIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CATTLE; CELL PERMEABILIZATION; CHROMAFFIN CELL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG EXPOSURE; DRUG INHIBITION; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENZYME INHIBITION; NONHUMAN;

EID: 0038025833     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.211     Document Type: Article

References (45)

1. Sata M, Sugiura S, Yamashita H, Aoyagi T, Momomura S and Serizawa T: Pimobendan directly sensitizes reconstituted thin filament to slide on cardiac myosin. Eur J Pharmacol 290, 55-59 (1995)
2. 2+ activation and the inotropic effect of pimobendan: Comparison with milrinone. Circ Res 63, 911-922 (1988)
3. Jaquet K and Heilmeyer LM Jr: Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin C. Biochem Biophys Res Commun 145, 1390-1396 (1987)
4. Ruegg JC, Pfitzer G, Eubler D and Zeugner C: Effect on contractility of skinned fibers from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy 1-3(2H)-pyridazinone. Arzneimittelforschung 34, 1736-1738 (1984)
5. Böhm M, Morano I, Pieske B, Ruegg JC, Wankerl M, Zimmermann R and Erdmann E: Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 68, 689-701 (1991)
6. Fujimoto S and Matsuda T: Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats. J Pharmacol Exp Ther 252, 1304-1311 (1990)
7. Brunkhorst D, Von Der Leyen H, Meyer W, Nigbur R, Schmidt-Schumacher C and Scholz H: Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 C1, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol 339, 575-583 (1989)
8. Fitton A and Brogden RN: Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure. Drugs Aging 5, 417-441 (1994)
9. Trifaró JM, Del Castillo AR and Vitale ML: Dynamic chenges in chromaffin cell cytoskelton as prelude to exocytosis. Mol Neurobiol 6, 339-358 (1992)
10. Trifaró JM, Bader MF and Doucet JP: Chromaffin cell cytoskeleton: Its possible role in secretion. Can J Biochem Cell Biol 63, 661-679 (1985)
11. Lee RW, Mushynski WE and Trifaró JM: Two forms of cytoplasmic actin in adrenal chromaffin cells. Neurosci 4, 843-852 (1979)
12. Creutz CE: Isolation, characterization and localization of bovine adrenal medullary myosin. Cell Tissue Res 178, 17-38 (1977)
13. Livett BG: Adrenal medullary chromaffin cells in vitro. Physiol Rev 64, 1103-1161 (1984)
14. Wood PM and Bunge RR: Evidence that sensory axons are mitogenic for Schwann cells. Nature 256, 662-664 (1975)
15. 2+- and ATP-dependent catecholamine secretion from bovine adrenal chromaffin cells. J Auton Pharmacol 19, 115-121 (1999)
16. 2+ with quin2. Methods Enzymol 172, 230-262 (1989)
17. 2+ buffers. Methods Cell Biol 40, 3-29 (1994)
18. Douglas WW, Kanno T and Sampson SR: Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells: An analysis employing techniques of tissue culture. J Physiol (Lond) 191, 107-120 (1967)
19. Kidokoro Y, Miyazaki S and Ozawa S: Acetylcholine-induced membrane depolarization and potential fluctuations in the rat adrenal chromaffin cell. J Physiol (Lond) 324, 203-220 (1982)
20. Corcoran JJ and Kirshner N: Inhibition of calcium uptake, sodium uptake and catecholamine secretion by methoxyverapamil (D 600) in primary cultures of adrenal medulla cells. J Neurochem 40, 1106-1109 (1983)
21. Cena V, Nicolas GP, Sanchez GP, Kirpekar SM and Garcia AG: Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release. Neuroscience 10, 1455-1462 (1983)
22. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R and Gandia L: Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels. Nature 309, 69-71 (1984)
23. Choi AY, Cahill AL, Perry BD and Perlman RL: Histamine evokes greater increases in phosphatidylinositol metabolism and catecholamine secretion in epinephrine-containing than in norepinephrine-containing chromaffin cells. J Neurochem 61, 541-549 (1993)
24. 2+ in bovine adrenal chromaffin cells: Comparison of the effects of histamine and angiotensin II. J Neurochem 54, 946-953 (1990)
25. Plevin R and Boarder MR: Stimulation of formation of inositol phosphates in primary cultures of bovine adrenal chromaffin cells by angiotensin II, histamine, bradykinin, and carbacol. J Neurochem 51, 634-641 (1988)
26. Bunn SJ and Marley PD: Effects of angiotensin II on cultured, bovine adrenal medullary cells. Neuropeptides 13, 121-132 (1989)
27. McMillian MK, Tuominen RK, Hudson PM, Suh HH and Hong JS: Angiotensin II receptors are coupled to omega-conotoxin-sensitive calcium influx in bovine adrenal medullary chromaffin cells. J Neurochem 58, 1285-1291 (1992)
28. 2+ entry in bovine adrenal chromaffin cells. Different patterns induced by histamine and angiotensin II, and relationship to catecholamine release. J Cell Sci 105, 913-921 (1993)
29. Holz RW, Bittner MA, Peppers SC, Senter RA and Eberhard DA: MgATP-independent and MgATP-dependent exocytosis. Evidence that MgATP primes adrenal chromaffin cells to undergo exocytosis. J Biol Chem 264, 5412-5419 (1989)
30. Bittner MA and Holz RW: Kinetic analysis of secretion from permeabilized adrenal chromaffin cells reveals distinct components. J Biol Chem 267, 16219-16225 (1992)
31. Bittner MA and Holz RW: A temperature-sensitive step in exocytosis. J Biol Chem 267, 16226-16229 (1992)
32. Hay JC and Martin TFJ: Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins. J Cell Biol 1991, 139-151 (1992)
33. Lawrence GW, Weller U and Dolly JO: Botulinum A and the light chain of tetanus toxins inhibit distinct stages of MgATP-dependent catecholamine exocytosis from permeabilized chromaffin cells. Eur J Biochem 222, 325-333 (1994)
34. Parson TD, Coorssen JR, Horstmann H and Almers W: Docked granules, the exocytotic burst, and the need for ATP hydrolysis in endocrine cells. Neuron 15, 1085-1096 (1995)
35. 2+. J Auton Pharmacol 20, 31-36 (2000)
36. Tsujimoto A, Morita K, Kitayama S and Dohi T: Facilitation of acetycholine-evoked catecholamine release by cyclic AMP on isolated perfused dog adrenal glands. Arch Int Pharmacodyn Ther 279, 304-313 (1986)
37. Morita K, Dohi T, Kitayama S, Koyama Y and Tsujimoto A: Enhancement of stimulation-evoked catecholamine release from cultured bovine adrenal chromaffin cells by forskolin. J Neurochem 48, 243-247 (1987)
38. 2+ fluxes in cultured bovine adrenal chromaffin cells are enhanced by forskolin. J Neurochem 48, 248-252 (1987)
39. Koshika T, Nagayama T, Iizuka Y, Kimura T and Satoh S: Effects of NKH477, a forskolin derivative, and dibutyryl-cyclic AMP on adrenal catecholamine release in response to splanchnic nerve stimulation, acetycholine, DMPP and muscarine in anesthetized dogs. Fundam Clin Pharmacol 11, 512-518 (1997)
40. +. Biochem Biophys Acta 846, 388-393 (1985)
41. Marriott D, Adams M and Boarder MR: Effects of forskolin and prostaglandin E1 on stimulus secretion coupling in cultured bovine adrenal chromaffin cells. J Neurochem 50, 616-623 (1988)
42. Cheek TR and Burgoyne RD: Cyclic AMP inhibits both nicotine-induced actin disassembly and catecholamine secretion from bovine adrenal chromaffin cells. J Biol Chem 262, 11663-11666 (1987)
43. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T and Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265, 5267-5272 (1990)
44. Hidaka H, Inagaki M, Kawamoto S and Sasaki Y: Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041 (1984)
45. Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y and Hidaka H: Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol 59, 347-356 (2000)